Kaiser Permanente HIV Cohort Study

计划入组 282,368 人 · 首次发布于 2011 年 4 月 20 日

FLU-FIT Program at Kaiser Permanente Northern California

计划入组 7,465 人 · 首次发布于 2010 年 9 月 28 日

Explore Transplant @Home Within Kaiser Permanente Southern California

计划入组 977 人 · 首次发布于 2018 年 1 月 4 日

P53 agonists(Seattle Biomedical Research Institute/University of Washington)

OICR-10268

GRP78 inhibitors (Amgen/Cancer Research Technology/Institute of Cancer Research)

Northwest Permanente, P.C.

United States

JAPAN HEALTH & RESEARCH INSTITUTE

Japan

ALLEGHENY SINGER RESEARCH INSTITUTE

United States

Moderna's mRNA-1273 COVID-19 Vaccine Shows Promise in Phase 1 Trial, Advances to Phase 3 Testing

COVID-19 Linked to Increased Risk of Chronic Fatigue Syndrome, Study Finds

Kaiser Permanente Pharmacist Outlines Key Challenges in Value-Based Care Implementation